Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/envnCfbwocfEzKalRZAu

March 19, 2013
Sign upForwardArchiveAdvertiseRead more at SmartBrief.com
News for nuclear medicine and molecular imaging professionals
 
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.

  Top Story 
 
  • Hybrid imaging's promise for lymph node mapping in prostate cancer
    Combining near-infrared fluorescence with hybrid imaging techniques such as PET/MR or SPECT/CT can help improve sentinel lymph node mapping ahead of and during surgery in patients with prostate cancer metastases, according to a study published in The Journal of Nuclear Medicine. The imaging methods, while still being assessed for their potential in the clinical setting, may in the future provide surgical teams with a means to improve prostate cancer staging, researchers said. MolecularImaging.net (3/18) LinkedInFacebookTwitterEmail this Story
 
  ADVERTISEMENT  
The MEDRAD™ Intego™ is making personalized PET practical.
Clinicians are able to set weight-based dosing formulas to determine and administer an accurate, personalized dose for each unique patient. Precise delivery and dose-on-demand capabilities enable lower patient dosing, leading to better patient care. To learn more, click here.
  Clinical News & Research 
  • JNM review: Where will PET/MR prove most useful?
    PET/MR has come a long way since 2007, when the first device integrating both technologies was developed, according to a paper published in The Journal of Nuclear Medicine. "Given the complementary nature of each modality's strengths and weaknesses, integrating PET and MR imaging offers the opportunity to gain in a single examination many of the positive attributes of both and mitigate some of their limitations," researchers said. PET/MR has shown it can improve imaging of cancers of the head and neck as well as the pelvis, and the approach is useful for non-malignant growths, the study said. PET/MR is also showing future potential for imaging neuropsychiatric conditions and Alzheimer's disease, and it can be useful in patients whose radiation exposure must be limited. MolecularImaging.net (3/18) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  News from the Field 
  • Novartis unveils 2 apps for patients with cancer, other conditions
    Novartis Oncology introduced the My NET Manager application to help patients with neuroendocrine tumors gain better knowledge about the condition and be reminded about doctor visits and medication refills. The firm also unveiled the Clinical Trial Seek app to assist patients and doctors in seeking clinical studies on cancer and other conditions. MobiHealthNews.com (3/14) LinkedInFacebookTwitterEmail this Story
  Health Policy 
 
  • Sequestration threatens faster FDA reviews, Hamburg says
    Across-the-board sequestration cuts could hurt the FDA's efforts to accelerate new drug reviews, said FDA Commissioner Dr. Margaret Hamburg during MassBio's annual meeting. Hamburg said she hopes Congress will allow the agency to put user fees paid by drugmakers toward its operating expenses. Boston Herald (3/15) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  From SNMMI 
  • SNMMI launches Dose Optimization Site
    SNMMI has launched a new online resource for imaging professionals, referring physicians and the public on dose optimization for nuclear medicine and molecular imaging procedures. The information, available at www.snmmi.org/dose, is designed to help ensure patients receive the smallest possible amount of radiopharmaceutical that will provide the appropriate diagnostic information. LinkedInFacebookTwitterEmail this Story
  • On the Road with ASNC: April 9 in Providence, R.I.
    Plan to attend ASNC's local learning initiative in April, offered in collaboration with SNMMI. Local needs and concerns will drive the agenda while the focus will be on quality improvement, including radiation dose in cardiac imaging, stress-only imaging and appropriate use criteria. Fellows, physicians, technologists and nurses — the whole care team — are welcome! CME/ACE credits will be provided. Register today. LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

  SmartQuote 
You may have to fight a battle more than once to win it."
--Margaret Thatcher,
British prime minister


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Account Director:   Meryl Harold   (202) 407-7828
 
Read more at SmartBrief.com
 
 
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.®  Legal Information